Inventor · disambiguated record
Francois Rousseau
Also filed as: ROUSSEAU FRANCOIS · ROUSSEAU FRANÇOIS
14 granted patents·8 pending applications·152 citations·filing 1990–2024
90Inventor score
Files withNOVIMMUNE SA12GALDERMA HOLDING S A2MASTERNAK KRZYSZTOF2ALLIANCE TECH IND1Ichnos Sciences SA1
Top patents by PatentIndex Score
22 records- 0193US5074809AUltraminiature high-frequency connection interfaceALLIANCE TECH IND·Filed 1990·Granted Dec 24, 1991·129 cites·18 claims
- 0283US8609093B2Methods of treatment using anti-IL-17F antibodiesMASTERNAK KRZYSZTOF·Filed 2012·Granted Dec 17, 2013·6 cites·12 claims
- 0379US8137671B2Anti-IL-17F antibodiesMASTERNAK KRZYSZTOF·Filed 2010·Granted Mar 20, 2012·4 cites·6 claims
- 0478US2024400720A1Anti-cd47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2024·Application pending·0 cites
- 0574US10400044B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2016·Granted Sep 3, 2019·1 cites·17 claims
- 0674US2022324994A1Anti-tlr4 antibodies and uses thereofNOVIMMUNE SA·Filed 2021·Application pending·0 cites
- 0773US11059910B2Anti-CD47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2013·Granted Jul 13, 2021·1 cites·7 claims
- 0872US9815909B2Readily isolated bispecific antibodies with native immunoglobulin formatNOVIMMUNE SA·Filed 2013·Granted Nov 14, 2017·1 cites·10 claims
- 0972US9475873B2Nucleic acids encoding anti-IL-17F antibodies and methods of use thereofNOVIMMUNE SA·Filed 2014·Granted Oct 25, 2016·1 cites·13 claims
- 1072US9453076B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2013·Granted Sep 27, 2016·1 cites·13 claims
- 1170US10982004B2Anti-TLR4 antibodies and uses thereofNOVIMMUNE SA·Filed 2019·Granted Apr 20, 2021·0 cites·11 claims
- 1264US2020231707A1Readily isolated bispecific antibodies with native immunoglobulin formatNOVIMMUNE SA·Filed 2019·Application pending·0 cites
- 1363US11840553B2Anti-CD47 antibodies and methods of use thereofNOVIMMUNE SA·Filed 2018·Granted Dec 12, 2023·0 cites·2 claims
- 1461US10494446B2Readily isolated bispecific antibodies with native immunoglobulin formatNOVIMMUNE SA·Filed 2017·Granted Dec 3, 2019·0 cites·7 claims
- 1555US2024141050A1Treatments for prurigo nodularisGALDERMA HOLDING S A·Filed 2023·Application pending·0 cites
- 1650US2022411518A1Treatments for prurigo nodularisGALDERMA HOLDING S A·Filed 2022·Application pending·0 cites
- 1749US2006040263A1Marker at the androgen receptor gene for determining breast cancer susceptibilitySIGNALGENE INC·Filed 2003·Application pending·0 cites
- 1847US11261262B2Readily isolated bispecific binding molecules with native format having mutated constant regionsNOVIMMUNE SA·Filed 2014·Granted Mar 1, 2022·0 cites·23 claims
- 1944US5834200AMarker at the estrogen receptor gene for determination of osteoporosis predispositionUNIV LAVAL CITE UNIVERSITAIRE·Filed 1997·Granted Nov 10, 1998·8 cites·12 claims
- 2044US2006099666A1Analyzer for the simultaneous enzymatic detection of closely related analytesMEDINOV INC·Filed 2003·Application pending·0 cites
- 2141US2020347143A1Novel tnfr agonists and uses thereofIchnos Sciences SA·Filed 2017·Application pending·0 cites
- 2220US5827677AMethod and device for specifically detecting myoglobin using a non-discriminating peroxidase sensitive assayUNIV LAVAL·Filed 1996·Granted Oct 27, 1998·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Francois Rousseau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →